FNDC5 and Alzheimer disease: There is now growing interest in the role of Irisin in AD as the molecule has been shown to potentially protect from the deposition of amyloid-β (Aβ) protein in the brain, a key molecular signature of AD pathology, by upregulating astrocytic release of Aβ-degrading enzymes [76].